Fluconazole OS40 mg/mL / 35 mL bottle
Back to Products
Brand name: DiFlucan®
1. Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, fluconazole for oral suspension USP was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia.
2. Cryptococcal meningitis. Before prescribing fluconazole for oral suspension USP for AIDS patients with cryptococcal meningitis, please see CLINICAL STUDIES section. Studies comparing fluconazole for oral suspension USP to amphotericin B in non-HIV infected patients have not been conducted.
Prophylaxis. Fluconazole for oral suspension USP is also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy.
For more information please see the prescribing information.
For more information please see the prescribing information on DailyMed.
|Product Name||Fluconazole OS|
|Dosage Form||Powder for Oral Suspension|
|Pack Size||35 mL bottle|
|Color||white to off-white powder|
|Gluten||Free from Gluten|
|Lactose||Free from Lactose|
|Soy||Free from Soy|
|Gelatin||Free from Gelatin|
|Allergen Info||Not Applicable|
|Other Product Info||Not Applicable|
sodium benzoate, citric acid anhydrous, sodium citrate, xanthan gum, titanium dioxide, natural orange flavor, colloidal silicon dioxide, and sucrose
Before Reconstitution: Store dry powder at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. After Reconstitution: Store reconstituted suspension between 5°C (41°F) and 25°C (77°F). Protect from freezing. Discard unused portion after 2 weeks.
|Product Shelf Life||24 months|
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.